FDA Adverse Event Malfunction Summary report: N

CHECK-IT

MDR report key: 15372944 · Received September 7, 2022

Report

Report Number
3016521623-2022-00335
Event Type
Malfunction
Date Received
September 7, 2022
Date of Event
August 25, 2022
Report Date
September 2, 2022
Manufacturer
LUCIRA HEALTH, INC.
Product Code
QJR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PRODUCT HAS NOT BEEN RETURNED. THEREFORE, A DHR REVIEW WAS COMPLETED FOR KIT LOT NUMBER: K07A110601224M1 WITH 0 DISCREPANCIES FOUND (ALL LOTS PASSED IN TOTAL PER THE SAMPLING PLAN). A REVIEW OF EXISTING CAPAS, SCARS AND NCMRS WERE COMPLETED AND THERE ARE NO PRIOR RECORDS RELATED TO "FALSE POSITIVE" FAILURE MODE FOR THIS LOT. THERE ARE 0 ADDITIONAL COMPLAINTS FROM THIS CUSTOMER NOR ANY OTHER CUSTOMER ASSOCIATED WITH A "FALSE POSITIVE" FAILURE MODE PRIOR TO THE REPORTED RECEIPT DATE OF AUGUST 25, 2022. BASED ON REVIEW OF THE PRODUCT'S FMEAS AND RISK ASSESSMENT DOCUMENTATION, FALSE POSITIVE TEST RESULTS ARE A KNOWN POSSIBLE OUTCOME REGARDING THIS ISSUE UNDER EVALUATION, REFER TO FMEA-001 AND FMEA-004. THE COMPLAINT RATE FOR "FALSE POSITIVE" IS UNDER THE EXPECTED THRESHOLD OF (B)(4) (LABEL CLAIM)/ (B)(4) (INTERNAL WARNING LIMIT). ACCORDING TO THE FAILURE RATE (B)(4) FOR THIS LOT, THE NUMBER OF FALSE POSITIVES (B)(4) IN RELATION TO THE TOTAL LOT QUANTITY PRODUCED (B)(4) IS UNDER THE EXPECTED THRESHOLD. KIT LOT#: K07A110601224M1 DHR REVIEW REFERENCE: SAMPLE VIAL LOT DHR REVIEW: 2112059, 2112150, 2112166, 2112167, 2112189, 2112199, 2112229, 2112293, 2112259, 2112294, 2112260, 2112261, 2112317, 2112318, 2112058 (ASSOCIATED INTERNAL LOT#: 211087-3H, 211087-3N, 211087-3P, 211087-3Q , 211087-3T, 211087-2W, 211087-2Y, 211087-4O, 211087-4B, 211087-4C, 211087-4G, 211087-4H, 211087-4M, 211087-4N, 211087-3G) TEST LOT DHRS REVIEW: 2112128, 2112128, 2112158, 2112174, 2112174, 2112174, 2112192, 2112192, 2112210, 2112212, 2112248, 2112302, 2112327, 2112356, 2112405, 2112047, 2112047, 2112107, 2112107 (ASSOCIATED INTERNAL LOT 211275-2C, 211275-2D, 211275-2E, 211275-2F, 211275-2H, 211275-2J, 211275-2L, 211275-2N, 211275-2O, 211275-2Q, 211275-2S, 211275-2X, 2114921-1A, 2114921-1I, 2114921-1N, 211275-1W, 211275-1X, 211275-2A, 211275-2B). BASED ON THE LIMITED INFORMATION AVAILABLE, ROOT CAUSE CANNOT BE DETERMINED. POTENTIAL ROOT CAUSES INCLUDE BUT ARE NOT LIMITED TO: ENVIRONMENTAL CONTAMINATION, LOW VIRAL LOAD, AND/OR DEVICE FAILURE. A SUPPLEMENTAL REPORT WILL BE FILED IF ANY FURTHER INVESTIGATION AND/OR ADDITIONAL INFORMATION IS OBTAINED. BASED ON THE COMPLAINT REVIEW, NO HARM WAS REPORTED WITHIN THE COMPLAINT. THIS DEVICE IS MARKETED UNDER EUA: (B)(4) CHECK-IT. EXPIRATION DATE OF KIT LOT NUMBER: K07A110601224M1-12/23/2022.

Description of Event or Problem · 0

ONE DEVICE REPORTED AS HAVING AN ALLEGED FALSE POSITIVE RESULT. THE COMPLAINANT PERFORMED A LUCIRA TEST WITH A POSITIVE RESULT AND RETESTED WITH A PCR TEST (16 HOURS AFTER THE LUCIRA POSITIVE RESULT) RECEIVING A NEGATIVE RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2485827 CHECK-IT COVID-19 TEST KIT QJR LUCIRA HEALTH, INC. K07A110601224M1

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other